Strategies to Better Align Investments in Pharmaceutical Innovation with Unmet Health Needs
The Center has partnered with Gates Ventures to fund a multi-year research initiative led by the National Academies of Sciences, Engineering, and Medicine. This initiative will be carried out by an independent committee of multi-disciplinary experts who will assess the relationship between investment in pharmaceutical innovation and the nation’s health needs.
Groundbreaking California-Civica Rx Partnership Will Increase Access to Low-Cost Insulin
The Peterson Center on Healthcare supports the growing national movement toward lower costs and improved outcomes in healthcare.
Peterson Center on Healthcare Announces $5M Support for New Effort to Manufacture and Distribute Low-Cost Insulin
The Peterson Center on Healthcare announced $5 million of funding to CivicaRx to support an innovative effort to create low-cost insulin.
Three National Foundations Commit $30 Million to Civica Rx, a Groundbreaking Effort to Address Shortages and High Prices of Life-saving Medications
To address shortages and rising prices, three national foundations committed $30 million to help establish Civica Rx, a nonprofit generic drug company.